CD6 and Syntaxin Binding Protein 6 Variants and Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis

• Sophine B. Krintel ,

  * E-mail: krintel@sophine.dk

  Affiliation DANBIO Registry and Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark

  ⨯
• Laurent Essioux,

  Affiliation Hoffmann-La Roche AG, Basel, Switzerland

  ⨯
• Assaf Wool,

  Affiliation Compugen Ltd., Tel Aviv, Israel

  ⨯
• Julia S. Johansen,

  Affiliations Department of Medicine, Copenhagen University Hospital at Herlev, University of Copenhagen, Copenhagen, Denmark, Department of Oncology, Copenhagen University Hospital at Herlev, University of Copenhagen, Copenhagen, Denmark, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Ehud Schreiber,

  Affiliation Compugen Ltd., Tel Aviv, Israel

  ⨯
• Tomer Zekharya,

  Affiliation Compugen Ltd., Tel Aviv, Israel

  ⨯
• Pinchas Akiva,

  Affiliation Compugen Ltd., Tel Aviv, Israel

  ⨯
• Mikkel Østergaard,

  Affiliations DANBIO Registry and Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Merete L. Hetland

  Affiliations DANBIO Registry and Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯